Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.66 and traded as low as C$1.54. Aptose Biosciences shares last traded at C$1.57, with a volume of 2,488 shares trading hands.
Aptose Biosciences Stock Down 1.9%
The business’s 50 day moving average price is C$1.66 and its 200-day moving average price is C$2.13. The firm has a market capitalization of C$4.01 million, a PE ratio of -0.20 and a beta of -0.12. The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05.
Aptose Biosciences Company Profile
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Further Reading
- Five stocks we like better than Aptose Biosciences
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Comparing and Trading High PE Ratio Stocks
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What is the S&P 500 and How It is Distinct from Other Indexes
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
